<p>百克国际公司（NYSE:BAX - 获取免费报告）在周四创下 52 周新低，此前该公司公布的季度收益低于预期。该股最低交易价为 24.73 美元，最后交易价为 22.98 美元，成交量为 139193 股。该股此前收盘价为 28.05 美元。</p>
<ul>
<li>医疗科技股票的价值加深：反转即将来临</li>
</ul>
<p>这家医疗器械供应商报告本季度每股收益为 0.59 美元，低于分析师一致预期的 0.60 美元，差距为 0.01 美元。百克国际的净利润率为-4.71%，股本回报率为 17.24%。百克国际本季度的收入较去年同期增长了 4.3%。在去年同期，该公司每股收益为 0.68 美元。</p>
<p>获取 <strong>百克国际</strong> 的提醒：</p>
<h2>百克国际分红公告</h2>
<p>该公司最近宣布了一项季度分红，将于 10 月 1 日（星期三）支付。8 月 29 日（星期五）登记的股东将获得 0.17 美元的分红。这相当于年化 0.68 美元的分红和 2.90% 的分红收益率。除息日期为 8 月 29 日（星期五）。百克国际目前的分红支付比率为-61.82%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>这 5 家医疗科技公司即将迎来重大反转</li>
</ul>
<p>几位股票分析师最近对 BAX 股票发表了评论。花旗集团在 7 月 9 日的研究报告中将百克国际的目标价从 34.00 美元下调至 32.00 美元，并对该股给予 “中性” 评级。摩根士丹利在 7 月 15 日的报告中将百克国际的目标价从 28.00 美元下调至 27.00 美元，并对该股给予 “减持” 评级。华尔街 Zen 在 6 月 22 日的报告中将百克国际的评级从 “持有” 上调至 “买入”。富国银行在 5 月 2 日的研究报告中将百克国际的目标价从 36.00 美元下调至 33.00 美元，并对该股给予 “等权重” 评级。最后，Evercore ISI 在 7 月 8 日的研究报告中将百克国际的目标价从 44.00 美元下调至 42.00 美元，并对该公司给予 “跑赢大盘” 评级。一位研究分析师对该股给予了卖出评级，三位给予了持有评级，六位给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 36.38 美元。</p>
<p><strong>查看我们关于百克国际的最新报告</strong></p>
<h2>对百克国际的对冲基金看法</h2>
<ul>
<li>购买高收益分红王 3M 的 5 个好理由</li>
</ul>
<p>一些机构投资者和对冲基金最近增加或减少了对 BAX 的持股。全州公司在第四季度购买了价值 45 万美元的百克国际新股份。Geode Capital Management LLC 在第四季度将其在百克国际的持股增加了 2.4%。Geode Capital Management LLC 目前拥有 12446939 股该医疗器械供应商的股票，价值 362006000 美元，此前在上个季度购买了额外的 290279 股。Oarsman Capital Inc.在第四季度购买了价值 157000 美元的百克国际新股份。拉塞尔投资集团在第四季度将其在百克国际的持股增加了 40.4%。拉塞尔投资集团目前拥有 1745709 股该医疗器械供应商的股票，价值 50904000 美元，此前在上个季度购买了额外的 502370 股。最后，Jaffetilchin Investment Partners LLC 在第四季度将其在百克国际的持股增加了 115259.6%。Jaffetilchin Investment Partners LLC 目前拥有 65755 股该医疗器械供应商的股票，价值 1917000 美元，此前在上个季度购买了额外的 65698 股。90.19% 的股票由机构投资者持有。</p>
<h2>百克国际股价下跌 16.4%</h2>
<p>该公司的 50 日简单移动平均线为 29.86 美元，200 日简单移动平均线为 31.14 美元。该公司的债务与股本比率为 1.33，流动比率为 2.02，速动比率为 1.40。该公司的市值为 120.3 亿美元，市盈率为-21.07，市盈增长比率为 0.85，贝塔值为 0.61。</p>
<h2>关于百克国际</h2>
<p>（获取免费报告）</p>
<p>百克国际公司通过其子公司在全球开发和提供一系列医疗保健产品。该公司通过四个部门运营：医疗产品与疗法、医疗系统与技术、制药和肾脏护理。该公司提供无菌静脉注射（IV）溶液；输液系统和设备；肠外营养疗法；通用注射药物；外科止血和密封产品，先进的外科设备；智能床系统；患者监测和诊断技术；以及呼吸健康设备，以及用于外科领域的先进设备，包括外科视频技术、精确定位设备和其他配件。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票超过百克国际</li>
<li>5 个适合分红增长投资者的折扣机会</li>
<li>消费者信心上升可能惠及这 3 只零售股票</li>
<li>如何从价值投资中获利</li>
<li>2 家网络安全巨头即将迎来重大突破</li>
<li>什么是分红冠军？如何投资于冠军</li>
<li>Spotify 第二季度收益暴跌：机会还是不祥信号？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在百克国际吗？</h2>
<p>在考虑巴克斯特国际之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而巴克斯特国际并不在名单上。</p>
<p>虽然巴克斯特国际目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>巴克斯特国际（Baxter International，NYSE:BAX）在季度财报令人失望后，股价创下 52 周新低 22.98 美元，每股收益（EPS）为 0.59 美元，未能达到分析师的预期。公司的收入同比增长 4.3%，但报告了 4.71% 的负净利润率。巴克斯特还宣布季度股息为 0.17 美元，收益率为 2.90%。分析师对该股票的评级不一，平均目标价为 36.38 美元。机构投资者持有 90.19% 的股份，该股票近期下跌了 16.4%</p>

<p>Baxter International Inc. (NYSE:BAX - Get Free Report) hit a new 52-week low on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $24.73 and last traded at $22.98, with a volume of 139193 shares. The stock had previously closed at $28.05.</p>
<div class="lb-trans"><p>百克国际公司（NYSE:BAX - 获取免费报告）在周四创下 52 周新低，此前该公司公布的季度收益低于预期。该股最低交易价为 24.73 美元，最后交易价为 22.98 美元，成交量为 139193 股。该股此前收盘价为 28.05 美元。</p>
</div><ul>
<li>The Value Deepens for Medtech Stocks: Reversal Imminent</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗科技股票的价值加深：反转即将来临</li>
</ul>
</div><p>The medical instruments supplier reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). Baxter International had a negative net margin of 4.71% and a positive return on equity of 17.24%. Baxter International's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.68 EPS.</p>
<div class="lb-trans"><p>这家医疗器械供应商报告本季度每股收益为 0.59 美元，低于分析师一致预期的 0.60 美元，差距为 0.01 美元。百克国际的净利润率为-4.71%，股本回报率为 17.24%。百克国际本季度的收入较去年同期增长了 4.3%。在去年同期，该公司每股收益为 0.68 美元。</p>
</div><p>Get <strong>Baxter International</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>百克国际</strong> 的提醒：</p>
</div><h2>Baxter International Dividend Announcement</h2>
<div class="lb-trans"><h2>百克国际分红公告</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.90%. The ex-dividend date is Friday, August 29th. Baxter International's dividend payout ratio is presently -61.82%.</p>
<div class="lb-trans"><p>该公司最近宣布了一项季度分红，将于 10 月 1 日（星期三）支付。8 月 29 日（星期五）登记的股东将获得 0.17 美元的分红。这相当于年化 0.68 美元的分红和 2.90% 的分红收益率。除息日期为 8 月 29 日（星期五）。百克国际目前的分红支付比率为-61.82%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>A Significant Reversal is in Sight for These 5 Med Tech Companies</li>
</ul>
<div class="lb-trans"><ul>
<li>这 5 家医疗科技公司即将迎来重大反转</li>
</ul>
</div><p>Several equities analysts have recently commented on BAX shares. Citigroup decreased their price target on Baxter International from $34.00 to $32.00 and set a &#34;neutral&#34; rating on the stock in a research note on Wednesday, July 9th. Morgan Stanley cut their price target on Baxter International from $28.00 to $27.00 and set an &#34;underweight&#34; rating on the stock in a report on Tuesday, July 15th. Wall Street Zen upgraded Baxter International from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Sunday, June 22nd. Wells Fargo &amp; Company dropped their price target on Baxter International from $36.00 to $33.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Friday, May 2nd. Finally, Evercore ISI decreased their price objective on Baxter International from $44.00 to $42.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, July 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $36.38.</p>
<div class="lb-trans"><p>几位股票分析师最近对 BAX 股票发表了评论。花旗集团在 7 月 9 日的研究报告中将百克国际的目标价从 34.00 美元下调至 32.00 美元，并对该股给予 “中性” 评级。摩根士丹利在 7 月 15 日的报告中将百克国际的目标价从 28.00 美元下调至 27.00 美元，并对该股给予 “减持” 评级。华尔街 Zen 在 6 月 22 日的报告中将百克国际的评级从 “持有” 上调至 “买入”。富国银行在 5 月 2 日的研究报告中将百克国际的目标价从 36.00 美元下调至 33.00 美元，并对该股给予 “等权重” 评级。最后，Evercore ISI 在 7 月 8 日的研究报告中将百克国际的目标价从 44.00 美元下调至 42.00 美元，并对该公司给予 “跑赢大盘” 评级。一位研究分析师对该股给予了卖出评级，三位给予了持有评级，六位给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 36.38 美元。</p>
</div><p><strong>Check Out Our Latest Report on Baxter International</strong></p>
<div class="lb-trans"><p><strong>查看我们关于百克国际的最新报告</strong></p>
</div><h2>Hedge Funds Weigh In On Baxter International</h2>
<div class="lb-trans"><h2>对百克国际的对冲基金看法</h2>
</div><ul>
<li>5 Good Reasons it's Time to Buy High-Yield Dividend King 3M</li>
</ul>
<div class="lb-trans"><ul>
<li>购买高收益分红王 3M 的 5 个好理由</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently added to or reduced their stakes in BAX. Allstate Corp bought a new position in Baxter International during the 4th quarter valued at $450,000. Geode Capital Management LLC lifted its holdings in shares of Baxter International by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 12,446,939 shares of the medical instruments supplier's stock valued at $362,006,000 after purchasing an additional 290,279 shares in the last quarter. Oarsman Capital Inc. purchased a new stake in shares of Baxter International in the fourth quarter valued at $157,000. Russell Investments Group Ltd. lifted its holdings in shares of Baxter International by 40.4% in the fourth quarter. Russell Investments Group Ltd. now owns 1,745,709 shares of the medical instruments supplier's stock valued at $50,904,000 after purchasing an additional 502,370 shares in the last quarter. Finally, Jaffetilchin Investment Partners LLC raised its holdings in shares of Baxter International by 115,259.6% during the fourth quarter. Jaffetilchin Investment Partners LLC now owns 65,755 shares of the medical instruments supplier's stock worth $1,917,000 after acquiring an additional 65,698 shares in the last quarter. 90.19% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近增加或减少了对 BAX 的持股。全州公司在第四季度购买了价值 45 万美元的百克国际新股份。Geode Capital Management LLC 在第四季度将其在百克国际的持股增加了 2.4%。Geode Capital Management LLC 目前拥有 12446939 股该医疗器械供应商的股票，价值 362006000 美元，此前在上个季度购买了额外的 290279 股。Oarsman Capital Inc.在第四季度购买了价值 157000 美元的百克国际新股份。拉塞尔投资集团在第四季度将其在百克国际的持股增加了 40.4%。拉塞尔投资集团目前拥有 1745709 股该医疗器械供应商的股票，价值 50904000 美元，此前在上个季度购买了额外的 502370 股。最后，Jaffetilchin Investment Partners LLC 在第四季度将其在百克国际的持股增加了 115259.6%。Jaffetilchin Investment Partners LLC 目前拥有 65755 股该医疗器械供应商的股票，价值 1917000 美元，此前在上个季度购买了额外的 65698 股。90.19% 的股票由机构投资者持有。</p>
</div><h2>Baxter International Trading Down 16.4%</h2>
<div class="lb-trans"><h2>百克国际股价下跌 16.4%</h2>
</div><p>The company has a fifty day simple moving average of $29.86 and a two-hundred day simple moving average of $31.14. The company has a debt-to-equity ratio of 1.33, a current ratio of 2.02 and a quick ratio of 1.40. The company has a market capitalization of $12.03 billion, a P/E ratio of -21.07, a price-to-earnings-growth ratio of 0.85 and a beta of 0.61.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 29.86 美元，200 日简单移动平均线为 31.14 美元。该公司的债务与股本比率为 1.33，流动比率为 2.02，速动比率为 1.40。该公司的市值为 120.3 亿美元，市盈率为-21.07，市盈增长比率为 0.85，贝塔值为 0.61。</p>
</div><h2>About Baxter International</h2>
<div class="lb-trans"><h2>关于百克国际</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.</p>
<div class="lb-trans"><p>百克国际公司通过其子公司在全球开发和提供一系列医疗保健产品。该公司通过四个部门运营：医疗产品与疗法、医疗系统与技术、制药和肾脏护理。该公司提供无菌静脉注射（IV）溶液；输液系统和设备；肠外营养疗法；通用注射药物；外科止血和密封产品，先进的外科设备；智能床系统；患者监测和诊断技术；以及呼吸健康设备，以及用于外科领域的先进设备，包括外科视频技术、精确定位设备和其他配件。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Baxter International</li>
<li>5 discounted opportunities for dividend growth investors</li>
<li>Higher Consumer Confidence Could Benefit These 3 Retail Stocks</li>
<li>How to Profit From Value Investing</li>
<li>2 Cybersecurity Giants Nearing Big Potential Breakouts</li>
<li>What Are Dividend Champions? How to Invest in the Champions</li>
<li>Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过百克国际</li>
<li>5 个适合分红增长投资者的折扣机会</li>
<li>消费者信心上升可能惠及这 3 只零售股票</li>
<li>如何从价值投资中获利</li>
<li>2 家网络安全巨头即将迎来重大突破</li>
<li>什么是分红冠军？如何投资于冠军</li>
<li>Spotify 第二季度收益暴跌：机会还是不祥信号？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Baxter International Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在百克国际吗？</h2>
</div><p>Before you consider Baxter International, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑巴克斯特国际之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baxter International wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而巴克斯特国际并不在名单上。</p>
</div><p>While Baxter International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然巴克斯特国际目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

百特国际（NYSE:BAX）因业绩不佳创下新的 52 周低点